Counting costs. Patients will suffer from limits on Alzheimer's drugs.
Draft guidelines from the National Institute for Health and Clinical Excellence (NICE), currently out for consultation, have suggested that drugs for the treatment of Alzheimer's disease should not be prescribed on the NHS. If this becomes policy, much of the proactive work in dementia care could be lost.